Influence
July 21, 2025

Association of smoking cannabis with cardiovascular events among Veterans with coronary artery disease

Dawn Bravata, MD

Published in the Circulation. Here is a link to the article.

Regenstrief Institute authors: Dawn Bravata, M.D.

A new study brings reassuring news for older adults using cannabis: smoking or consuming cannabis does not appear to raise the risk of heart attacks, strokes or cardiovascular death—at least among older veterans with pre-existing heart disease.

Researchers examined 4,285 U.S. veterans, aged 66 to 68, who were born between 1950 and 1952 and had been diagnosed with coronary artery disease. Participants were enrolled in the THC (Heart and Cannabis) Cohort between April 2018 and March 2020. They were interviewed about their cannabis use in the prior 30 days, including whether they smoked, vaped or consumed edibles.

The study tracked each participant for an average of 3.3 years, analyzing the risk of major cardiovascular events, including fatal and nonfatal heart attacks, strokes and cardiovascular-related deaths.

Among the group, 1,015 veterans reported recent cannabis smoking, while 3,122 reported no recent use. In total, 563 cardiovascular events occurred during the follow-up. However, researchers found no significant link between cannabis use and increased cardiovascular risk. Smoking cannabis was associated with a slightly lower but not statistically significant hazard ratio (0.87; 95% CI, 0.61–1.24), and no form of cannabis use—smoking, vaping or edibles—showed a heightened risk.

The findings suggest that, at least in this older population with heart disease, cannabis use may not independently elevate the risk of serious cardiovascular events. Researchers caution, however, that further studies are needed to evaluate long-term effects and outcomes in broader populations.

Authors: 

Salomeh Keyhani1,2, Beth E Cohen1,2, Marzieh Vali3, Katherine J Hoggatt1,2, Dawn M Bravata4,5, Peter C Austin6, Emily Lum3, Deborah Hasin7, Carl Grunfeld1,2, Michael G Shlipak1,2,8

Affiliations: 

1Center for Data to Discovery and Delivery Innovation, San Francisco Veterans Administration, CA (S.K., B.E.C., K.J.H., C.G., M.G.S.).

2Department of Medicine, University of California, San Francisco. (S.K., B.E.C., K.J.H., C.G., M.G.S.).

3Northern California Institute for Research and Education, San Francisco (M.V., E.L.).

4Center for Health Information and Communication, Richard L. Roudebush VA Medical Center, Indianapolis, IN (D.M.B.).

5Department of Medicine, Indiana University School of Medicine, Indianapolis (D.M.B.).

6University of Toronto, Canada (P.C.A.).

7Department of Psychiatry, Vagelos School of Medicine, Columbia University, New York, NY (D.H.).

8Department of Epidemiology and Biostatistics, University of California, San Francisco. (M.G.S.).

Partners

Related News

Dr. Babar Khan on All IN

Renowned delirium researcher and clinician named Regenstrief interim center director

Babar Khan, M.D., M.S., a renowned delirium research scientist and pulmonary and critical care clinician, has been named interim

Regenstrief Research Scientist Wanzhu Tu, PhD

Parental liver disease death more than doubles risk of alcohol-associated hepatitis in next generation

In a groundbreaking study, research scientists from the Indiana University School of Medicine and Regenstrief Institute found that individuals

image of elderly woman discussing pill bottle with her doctor

American Geriatrics Society unveils updated alternatives to potentially harmful medications for older adults

Regenstrief researcher serves on expert panel providing clinicians, patients and families with credible, actionable alternatives The American Geriatrics Society

Regenstrief experts drive global dialogue on AI in healthcare at MedInfo 2025

Regenstrief experts drive global dialogue on AI in healthcare at MedInfo 2025

Regenstrief Institute research scientists and professional staff joined presenters from around the world at the MedInfo 2025 conference from